U.S. Senators Baldwin and McCain to President Trump: Hold the Pharmaceutical Industry Accountable for Skyrocketing Prescription Drug Prices
WASHINGTON, D.C. – U.S. Senators Tammy Baldwin (D-WI) and John McCain (R-AZ) today sent a letter to President Trump urging him to hold the pharmaceutical industry accountable and make good on his promise to lower the skyrocketing prescription drug costs that American families are struggling to afford.
“We have offered a simple bipartisan solution that holds the pharmaceutical industry accountable and institutes basic transparency,” the senators continued. “We stand ready to work with you and our colleagues in Congress to address skyrocketing prescription drug prices so that American families can finally be afforded the relief they so desperately need.”
Senators Baldwin and McCain co-authored the FAIR Drug Pricing Act, which would address skyrocketing prescription drug prices and hold pharmaceutical companies accountable by requiring transparency for pharmaceutical corporations that plan to increase drug prices. The bill would not prohibit manufacturers from increasing prices, but it would, for the first time, give taxpayers notice of price increases and bring basic transparency to the market for prescription drugs.
The full letter is available here.
An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. It has not been verified for its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin Announces $4.9 Million to Protect and Restore Wisconsin’s Coastal Habitats
Apr 23rd, 2024 by U.S. Sen. Tammy BaldwinFunding from Baldwin-backed Bipartisan Infrastructure Law will increase resilience to climate change and extreme weather events
